Niddk: supply: procurement of deuterium oxide (d, 70%) for metabolic research - severable
Ended Purchase Order Awarded Last action
- Contract number
- 75N94025P00575
- Awardee
-
Cambridge Isotope Laboratories, Inc. UEI JNBGUL51AVL8
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,788
Award facts
- Contract value 100% obligated
- $14,788.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325180 Other Basic Inorganic Chemical Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Andover, MA 01810, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed-price purchase order to Cambridge Isotope Laboratories, Inc. for the procurement of deuterium oxide (D, 70%) to support metabolic research initiatives. The contract, valued at $14,788.00, was awarded on September 8, 2025, with an ultimate completion date of January 8, 2026. Cambridge Isotope Laboratories, a foreign-owned manufacturer headquartered in Andover, Massachusetts, specializes in producing stable isotopes and isotope-labeled compounds essential for biomedical research and pharmaceutical development. The work will be performed at the contractor's facility in Andover, MA. This procurement carries no set-aside designation, indicating the award was made through open competition.
Cambridge Isotope Laboratories serves as a critical supplier of specialized isotopic materials to multiple NIH institutes and operates under a significant $10 million blanket purchase agreement with the NIH Office of Logistics and Acquisition Operations extending through January 2026. Deuterium oxide is a fundamental tracer compound utilized in metabolic studies to track biochemical processes and nutrient utilization in research applications. The contractor's extensive track record with NIDDK and other NIH institutes—including the National Institute of Mental Health, National Institute on Drug Abuse, and National Institute on Aging—demonstrates its established capability to deliver high-quality isotopically labeled compounds on schedule and within budget parameters for federally funded biomedical research programs.
Quick answers
Who was awarded contract 75N94025P00575?
75N94025P00575 was awarded to Cambridge Isotope Laboratories, Inc. by National Institute of Child Health and Human Development (National Institutes of Health) on September 8, 2025.
How much is contract 75N94025P00575 worth?
The government has obligated $14,788 on 75N94025P00575.
Which agency awarded contract 75N94025P00575?
National Institute of Child Health and Human Development (National Institutes of Health) awarded 75N94025P00575, with funding from National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health).
Was contract 75N94025P00575 competed?
The extent of competition for 75N94025P00575 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award